411 related articles for article (PubMed ID: 25576361)
1. A bidirectional drug repositioning approach for Parkinson's disease through network-based inference.
Rakshit H; Chatterjee P; Roy D
Biochem Biophys Res Commun; 2015 Feb; 457(3):280-7. PubMed ID: 25576361
[TBL] [Abstract][Full Text] [Related]
2. Drug Repositioning to Accelerate Drug Development Using Social Media Data: Computational Study on Parkinson Disease.
Zhao M; Yang CC
J Med Internet Res; 2018 Oct; 20(10):e271. PubMed ID: 30309833
[TBL] [Abstract][Full Text] [Related]
3. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
[TBL] [Abstract][Full Text] [Related]
4. Combining Human Disease Genetics and Mouse Model Phenotypes towards Drug Repositioning for Parkinson's disease.
Chen Y; Cai X; Xu R
AMIA Annu Symp Proc; 2015; 2015():1851-60. PubMed ID: 26958284
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Drug Repositioning for Alzheimer's Disease Based on Epigenetic Targets in Human Interactome.
Chatterjee P; Roy D; Rathi N
J Alzheimers Dis; 2018; 61(1):53-65. PubMed ID: 29199645
[TBL] [Abstract][Full Text] [Related]
6. Drug Repurposing in Parkinson's Disease.
Athauda D; Foltynie T
CNS Drugs; 2018 Aug; 32(8):747-761. PubMed ID: 30066310
[TBL] [Abstract][Full Text] [Related]
7. A review of network-based approaches to drug repositioning.
Lotfi Shahreza M; Ghadiri N; Mousavi SR; Varshosaz J; Green JR
Brief Bioinform; 2018 Sep; 19(5):878-892. PubMed ID: 28334136
[TBL] [Abstract][Full Text] [Related]
8. Advances in drug development for Parkinson's disease: present status.
Harikrishna Reddy D; Misra S; Medhi B
Pharmacology; 2014; 93(5-6):260-71. PubMed ID: 25096413
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic screening of the Prestwick library for treatment of Parkinson's tremor symptoms using a humanized quantitative systems pharmacology platform.
Spiros A; Roberts P; Geerts H
J Parkinsons Dis; 2013; 3(4):569-80. PubMed ID: 24192755
[TBL] [Abstract][Full Text] [Related]
10. [Parkinson's Disease: amantadine, zonisamide, dabrafenib].
Okamoto T
Brain Nerve; 2019 Sep; 71(9):953-959. PubMed ID: 31506397
[TBL] [Abstract][Full Text] [Related]
11. DrugNet: network-based drug-disease prioritization by integrating heterogeneous data.
Martínez V; Navarro C; Cano C; Fajardo W; Blanco A
Artif Intell Med; 2015 Jan; 63(1):41-9. PubMed ID: 25704113
[TBL] [Abstract][Full Text] [Related]
12. Old wines in new bottles: Repurposing opportunities for Parkinson's disease.
Kakkar AK; Singh H; Medhi B
Eur J Pharmacol; 2018 Jul; 830():115-127. PubMed ID: 29689247
[TBL] [Abstract][Full Text] [Related]
13. Computational Drug Repositioning with Random Walk on a Heterogeneous Network.
Luo H; Wang J; Li M; Luo J; Ni P; Zhao K; Wu FX; Pan Y
IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(6):1890-1900. PubMed ID: 29994051
[TBL] [Abstract][Full Text] [Related]
14. Integrated network analysis identifying potential novel drug candidates and targets for Parkinson's disease.
Quan P; Wang K; Yan S; Wen S; Wei C; Zhang X; Cao J; Yao L
Sci Rep; 2021 Jun; 11(1):13154. PubMed ID: 34162989
[TBL] [Abstract][Full Text] [Related]
15. Predicting associations among drugs, targets and diseases by tensor decomposition for drug repositioning.
Wang R; Li S; Cheng L; Wong MH; Leung KS
BMC Bioinformatics; 2019 Dec; 20(Suppl 26):628. PubMed ID: 31839008
[TBL] [Abstract][Full Text] [Related]
16. Parkinson's disease pharmacogenomics: new findings and perspectives.
Schumacher-Schuh AF; Rieder CR; Hutz MH
Pharmacogenomics; 2014 Jun; 15(9):1253-71. PubMed ID: 25141900
[TBL] [Abstract][Full Text] [Related]
17. Rhythm-specific modulation of the sensorimotor network in drug-naive patients with Parkinson's disease by levodopa.
Esposito F; Tessitore A; Giordano A; De Micco R; Paccone A; Conforti R; Pignataro G; Annunziato L; Tedeschi G
Brain; 2013 Mar; 136(Pt 3):710-25. PubMed ID: 23423673
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacogenetics in Parkinson's disease treatment].
Białecka M; Kłodowska-Duda G; Kurzawski M; Droździk M
Neurol Neurochir Pol; 2008; 42(2):131-8. PubMed ID: 18512170
[TBL] [Abstract][Full Text] [Related]
19. Network mirroring for drug repositioning.
Park S; Lee DG; Shin H
BMC Med Inform Decis Mak; 2017 May; 17(Suppl 1):55. PubMed ID: 28539121
[TBL] [Abstract][Full Text] [Related]
20. Repositioning of drugs for Parkinson's disease and pharmaceutical nanotechnology tools for their optimization.
Hernández-Parra H; Cortés H; Avalos-Fuentes JA; Del Prado-Audelo M; Florán B; Leyva-Gómez G; Sharifi-Rad J; Cho WC
J Nanobiotechnology; 2022 Sep; 20(1):413. PubMed ID: 36109747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
